Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 09:30AM ET
22.35
Dollar change
-0.04
Percentage change
-0.18
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y11.50% Shs Outstand Perf Week-3.41%
SponsorInvesco ETF Type Tagsequity Return% 3Y-0.51% Total Holdings213 Perf Month-5.01%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM39.67M Perf Quarter-8.96%
IndexNASDAQ Biotechnology Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y-0.99%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year5.67%
Active/Passive Quant Type Tags- Flows% 1M3.06% 52W Range20.14 - 24.84 Perf YTD2.10%
Dividend TTM0.24 (1.06%) ESG Type Tags- Flows% 3M13.70% 52W High-10.02% Beta0.67
Dividend Ex-DateSep 23, 2024 Dividend Type Sector/Theme Flows% YTD98.16% 52W Low10.97% ATR (14)0.29
Expense0.19% Structure Type Region Flows% 1Y RSI (14)36.94 Volatility1.10% 1.34%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.08 Prev Close22.39
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume15.76K Price22.35
SMA20-1.59% SMA50-4.15% SMA200-2.48% Trades Volume75 Change-0.18%
Invesco Nasdaq Biotechnology ETF seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index . The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.